Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000899448) titled 'Use of the Novoglan Device and Steroid Cream in Adult Men With Phimosis' on Aug. 19.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Type of endpoint: Efficacy
Primary Sponsor: Monash Health
Condition:
Adult Phimosis
Adult Phimosis
Renal and Urogenital - Other renal and urogenital disorders
Intervention:
Participants will receive a combination of topical corticosteroid therapy and the Novoglan penile tissue expander as a non-surgical treatment for adult phimosis. The Novoglan device is a CE-marked Class 1 medical device designed to gently stretch the foreskin...